Short induction phase of contact allergy to tixocortol pivalate in a nasal spray.
Bircher
A J
AJ
Department of Dermatology, University of Basel, Switzerland.
D000281:Administration, Intranasal; D000287:Administration, Topical; D000336:Aerosols; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D003877:Dermatitis, Contact / Q000209:etiology*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D008875:Middle Aged; D012221:Rhinitis, Allergic, Perennial / Q000209:etiology*
D000336:Aerosols; D000893:Anti-Inflammatory Agents; C019112:tixocortol pivalate; D006854:Hydrocortisone